| __timestamp | Viatris Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 4050200000 | 2395000 |
| Thursday, January 1, 2015 | 5047100000 | 9057000 |
| Friday, January 1, 2016 | 6078400000 | 393000 |
| Sunday, January 1, 2017 | 6931500000 | 79309000 |
| Monday, January 1, 2018 | 6861900000 | 134428000 |
| Tuesday, January 1, 2019 | 7056300000 | 175431000 |
| Wednesday, January 1, 2020 | 8149300000 | 124165000 |
| Friday, January 1, 2021 | 12310800000 | 121875000 |
| Saturday, January 1, 2022 | 9765700000 | 10114000 |
| Sunday, January 1, 2023 | 8988300000 | 9206000 |
Data in motion
In the ever-evolving landscape of the pharmaceutical and biotechnology sectors, understanding cost structures is crucial. Viatris Inc. and Wave Life Sciences Ltd. offer a fascinating comparison. Over the past decade, Viatris Inc. has consistently reported a cost of revenue that dwarfs that of Wave Life Sciences Ltd. by a staggering ratio of approximately 113:1. This disparity highlights the scale and operational differences between a global pharmaceutical giant and a specialized biotech firm.
From 2014 to 2023, Viatris Inc.'s cost of revenue surged by over 120%, peaking in 2021. In contrast, Wave Life Sciences Ltd. experienced a more volatile trajectory, with its highest cost of revenue in 2019. This data underscores the diverse financial strategies and market positions of these companies, offering valuable insights for investors and industry analysts alike.
Cost of Revenue: Key Insights for AstraZeneca PLC and Viatris Inc.
Comparing Cost of Revenue Efficiency: Vertex Pharmaceuticals Incorporated vs Viatris Inc.
Cost of Revenue: Key Insights for Viatris Inc. and Jazz Pharmaceuticals plc
Viatris Inc. vs Ionis Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Viatris Inc. vs Vericel Corporation
Cost of Revenue: Key Insights for Viatris Inc. and Taro Pharmaceutical Industries Ltd.
Viatris Inc. vs MiMedx Group, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Bio-Techne Corporation vs Wave Life Sciences Ltd.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Wave Life Sciences Ltd.'s Expenses
Cost Insights: Breaking Down Exelixis, Inc. and Wave Life Sciences Ltd.'s Expenses
Comparing Cost of Revenue Efficiency: Vericel Corporation vs Wave Life Sciences Ltd.
Cost of Revenue: Key Insights for Wave Life Sciences Ltd. and Viridian Therapeutics, Inc.